John has a T-9 spinal cord injury and has a past history of developing AD (autonomic dysreflexia). Besides the prevention of bladder distention, what other measures can help reduce his risk for an AD episode?

John has a T-9 spinal cord injury and has a past history of developing AD (autonomic dysreflexia). Besides the prevention of bladder distention, what other measures can help reduce his risk for an AD episode?

• A. Alpha adrenergic agonist & prevention of UTIs
• B. Alpha adrenergic antagonist & prevention of constipation
• C. Anticholinergic & prevention of UTIs
• D. Calcium channel blocker & relaxation techniques

Answer: (B)

Autonomic dysreflexia happens when a noxious stimulus below the level of spinal cord injury triggers a massive sympathetic response, leading to a dangerous spike in blood pressure. Two major ways to reduce the risk are to prevent common triggers and to blunt the body's vasoconstrictive reaction when a trigger occurs. Preventing constipation is crucial because rectal distention is a well-known trigger for autonomic dysreflexia. Establishing a reliable bowel program, using stool softeners or laxatives as needed, and ensuring regular, easy-to-pass stools help minimize this trigger. Using an alpha-adrenergic antagonist can further reduce risk by blunting the vasoconstrictive surge that drives the high blood pressure during an episode. This pharmacologic approach complements trigger prevention and can lower the likelihood or severity of an autonomic dysreflexia event. Why the other options fit less well: an alpha-adrenergic agonist would worsen vasoconstriction and potentially trigger or exacerbate an episode; anticholinergic therapy is not specifically preventive for autonomic dysreflexia and can cause constipation or other issues; relying on a calcium channel blocker with relaxation techniques doesn’t address the key triggers as directly or reliably as preventing constipation and using an alpha-adrenergic antagonist.

Autonomic dysreflexia happens when a noxious stimulus below the level of spinal cord injury triggers a massive sympathetic response, leading to a dangerous spike in blood pressure. Two major ways to reduce the risk are to prevent common triggers and to blunt the body's vasoconstrictive reaction when a trigger occurs.

Preventing constipation is crucial because rectal distention is a well-known trigger for autonomic dysreflexia. Establishing a reliable bowel program, using stool softeners or laxatives as needed, and ensuring regular, easy-to-pass stools help minimize this trigger.

Using an alpha-adrenergic antagonist can further reduce risk by blunting the vasoconstrictive surge that drives the high blood pressure during an episode. This pharmacologic approach complements trigger prevention and can lower the likelihood or severity of an autonomic dysreflexia event.

Why the other options fit less well: an alpha-adrenergic agonist would worsen vasoconstriction and potentially trigger or exacerbate an episode; anticholinergic therapy is not specifically preventive for autonomic dysreflexia and can cause constipation or other issues; relying on a calcium channel blocker with relaxation techniques doesn’t address the key triggers as directly or reliably as preventing constipation and using an alpha-adrenergic antagonist.